Action 688639 ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Anhui Huaheng Biotechnology Co., Ltd.

Actions

688639

CNE1000052M6

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
118,4 CNY +1,07% Graphique intraday de Anhui Huaheng Biotechnology Co., Ltd. +10,14% -5,94%
22/04 Les bénéfices d'Anhui Huaheng Biotechnology augmentent de 7% au premier trimestre MT
22/04 Les bénéfices d'Anhui Huaheng Biotechnology pour 2023 augmentent de 40 MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Anhui Huaheng Biotechnology's Q1 Profit Jumps 7%
Anhui Huaheng Biotechnology's 2023 Profit Jumps 40%
Certain A Shares of Anhui Huaheng Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 22-APR-2024.
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Rate Cut Plans Boost China Stocks; Huaheng Biotechnology Jumps 9%
Huaheng Biotechnology to Set Up Subsidiary, Production Plant for 700 Million Yuan
Huaheng Biotechnology Gets Rights to Ouhe Biotechnology's Biological Arginine Production Technology
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback announced on August 11, 2023, has closed with 496,600 shares, representing 0.32% for CNY 49.98 million.
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
Anhui Huaheng Biotechnology Co., Ltd.(XSSC:688639) added to S&P Global BMI Index
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
Anhui Huaheng Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Anhui Huaheng Biotechnology Co., Ltd. authorizes a Buyback Plan.
Anhui Huaheng Biotechnology Acquires Marketing Rights to Ouhe Biotechnology's Phytic Acid Technology
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 688639
  4. Actualités Anhui Huaheng Biotechnology Co., Ltd.
  5. Autres langues